Ledger.Open graph →
SEC Form D · filed October 15, 2021

Woolsey Pharmaceuticals, Inc

Offering
—
Sold
$19.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

David M. Geliebter · NEW YORK, NYExec · DirectorSven M. Jacobson · NEW YORK, NYExec · DirectorDingan Fei · Grand Cayman, Cayman IslandsExec · DirectorScott Hutchins · Walpole, MAExec · DirectorMelanie P. Dow · New York, NYExec · DirectorDavid P. O'Connor · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗